An interventional study of MinADHD in ADHD, ADHD - Combined Type and ADHD Predominantly Inattentive Type, sponsored by Haukeland University Hospital. Active, not recruiting at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Haukeland University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Attention Deficit Disorder with Hyperactivity with a site in Norway — 4 open to participants now, 7 under way, none of them phase 3. Attention Deficit Disorder with Hyperactivity · Norway.
Among the 30 studies in Attention Deficit Disorder with Hyperactivity with a site in Norway, this one is the 7th largest by planned enrollment of the 25 interventional ones that give a count, is one of 2 that started in 2024, is one of 17 with no phase, and was the 27th registered.
1,821 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 297 are open to participants now.
Browse Attention Deficit Disorder with Hyperactivity studies →4 of the 30 studies in Attention Deficit Disorder with Hyperactivity with a site in Norway are open now. Recruiting first, the newest first:
Sorlandet Hospital HF · Sites in Norway
Ages 5–18 · Healthy volunteers
St. Olavs Hospital · Sites in Norway
Ages 18–65
Royal Devon and Exeter NHS Foundation Trust · Sites in Norway, United States, Italy and 1 more country
Ages 2–50
Solli Distriktspsykiatriske Senter · Sites in Norway
Ages 18+
A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →
Of the 200 Attention Deficit Disorder with Hyperactivity studies recruiting now, 26 (13%) set no upper age limit and 169 (85%) stop at 75 or younger; 141 take children under 18; 55 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 72 across 1,439 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.
Median enrollment 100 across the 25 interventional studies, 187 across the 5 observational. Of the 20 that completed or were terminated, 5 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 30 have an industry lead sponsor. The 10 most frequent:
Haukeland University Hospital is the lead sponsor of 284 studies on the registry; 58 are open to participants now.
Haukeland University Hospital has 3 studies filed under Attention Deficit Disorder with Hyperactivity — fewer than ten, so there is no comparison to draw.
3 of the studies in Attention Deficit Disorder with Hyperactivity with a site in Norway that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06284655St. Olavs HospitalThe Effect of a Brief Educational Intervention for Adults With ADHD | 2027-01 |
| NCT07675538Solli Distriktspsykiatriske SenterHigh Intensity Training for Adults With ADHD in Specialised Mental Health Care | 2027-06-01 |
| NCT06299189Haukeland University HospitalA Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care | 2027-09 |
Add all 3 to your calendar (.ics) → With an account.
Among the 30 studies in Attention Deficit Disorder with Hyperactivity with a site in Norway, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The primary objective of this study is to explore and evaluate the use and utility of a guided Internet-delivered psychological treatment for adults with ADHD with a combined focus on:
i) Evaluating the impact of potential predictors to treatment adherence, treatment response, treatment use and utilty. ii) Evaluating the feasibility, clinical benefits and implementation process of the treatment in routine outpatient care. iii) Evaluate the cost-effectiveness of the treatment program.
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms of inattention and/or hyperactivity/impulsivity that are persistent across time and situations. ADHD in adulthood, with estimated prevalence of 2-3%, is associated with challenges that may have severe consequences on daily life functioning. Treatments delivered over the Internet on smartphones or personal computers may help to increase the availability of effective psychological interventions for a larger group of adults with ADHD. The overall aim of this study is to investigate 1) predictors of effect; 2) implementation outcomes; and the 3) cost-benefit of a therapist guided Internet-delivered treatment for adults with an ADHD diagnosis. The study is an open longitudinal cohort trial in routine care. A total of 200 participants with an ADHD diagnosis will be included in the trial, and 15 participants will be interviewed about their experiences with guided Internet-delivered treatment. The outcomes are change in primary and secondary symptoms and quality of life, cost-benefit and implementation outcomes of guided internet-delivered treatment for adults with ADHD. The investigators will use quantitative statistical procedures and qualitative methods to analyze the data. The results from the study will contribute to the growing research on Internet-delivered treatments. The expected results may have a major impact on treatment provision and the further development of treatment options for adults with ADHD. Moreover, investigating ways to increase adoption, adherence and fidelity in Internet-delivered treatment could be of great value when implementing such treatment into routine care.
Inclusion criteria: \|
Exclusion criteria:
MinADHD: 7 self-help modules Interventions: Behavioural
Behavioral: MinADHD
Guided self-help, 7 modules Interventions
The Adult ADHD Self-Rating Scale
Measure of ADHD symptom severity
Time frame: From enrollment to the end of 6-months follow-up
Adult ADHD Quality of Life Measure
Measure of impact of ADHD on quality of life
Time frame: From enrollment til the end of 6-month follow-up.
The Patient Health Questionnaire
Measure of depression
Time frame: From enrollment til the end of 6-month follow-up.
Generalized Anxiety Disorder-7
Measure of anxiety
Time frame: From enrollment til the end of 6-month follow-up.
Personality Disorder Severity ICD-11
Measure of personality functioning
Time frame: From enrollment til the end of 6-month follow-up.
EuroQoL 5D-5L
Measure of health-related quality of life
Time frame: From enrollment to end of 6-month follow-up.
Plan to share: No — The IPD collected for the current trial is considered sensitive patient information.
No publications or documents are linked to this record.
Started Jan 2024 (actual). Primary completion is estimated for Sep 2027, 44 months after the start.
Of 480 non-industry interventional studies with no phase under Attention Deficit Disorder with Hyperactivity, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 44 months is above that.
Counting every sponsor, half of 511 studies reached it within 23 months; a quarter within 11 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Attention Deficit Disorder with Hyperactivity →
Haukeland University Hospital →